0001596783-20-000180.txt : 20201005
0001596783-20-000180.hdr.sgml : 20201005
20201005195506
ACCESSION NUMBER: 0001596783-20-000180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201002
FILED AS OF DATE: 20201005
DATE AS OF CHANGE: 20201005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiminski John R
CENTRAL INDEX KEY: 0001482197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 201225152
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_160194209323283.xml
FORM 4
X0306
4
2020-10-02
0
0001596783
Catalent, Inc.
CTLT
0001482197
Chiminski John R
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
1
1
0
0
Chair & CEO
Common Stock
2020-10-02
4
M
0
100372
31.96
A
404337
D
Common Stock
2020-10-02
4
F
0
64053
86.01
D
340284
D
Common Stock
2020-10-02
4
M
0
37763
24.44
A
378047
D
Common Stock
2020-10-02
4
F
0
22198
86.01
D
355849
D
Common Stock
2020-10-02
4
S
0
9191
85.27
D
346658
D
Common Stock
2020-10-02
4
S
0
173040
86.05
D
173618
D
Options to purchase Common Stock
31.96
2020-10-02
4
M
0
100372
0
D
2016-08-27
2025-08-27
Common Stock
100372.0
0
D
Options to purchase Common Stock
24.44
2020-10-02
4
M
0
37763
0
D
2026-07-26
Common Stock
37763.0
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
Includes restricted stock units.
Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
Represents shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $85.57 to $86.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On August 27, 2015, the reporting person was granted options to purchase 100,372 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on August 27, 2016.
On July 26, 2016, the reporting person was granted options to purchase 151,049 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 26, 2017.
/s/ Jose Ibietatorremendia, attorney-in-fact
2020-10-05